Correlation Between Day One and Oncolytics Biotech
Can any of the company-specific risk be diversified away by investing in both Day One and Oncolytics Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Oncolytics Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Day One Biopharmaceuticals and Oncolytics Biotech, you can compare the effects of market volatilities on Day One and Oncolytics Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Oncolytics Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Oncolytics Biotech.
Diversification Opportunities for Day One and Oncolytics Biotech
0.72 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Day and Oncolytics is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Oncolytics Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncolytics Biotech and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Oncolytics Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncolytics Biotech has no effect on the direction of Day One i.e., Day One and Oncolytics Biotech go up and down completely randomly.
Pair Corralation between Day One and Oncolytics Biotech
Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to generate 0.74 times more return on investment than Oncolytics Biotech. However, Day One Biopharmaceuticals is 1.35 times less risky than Oncolytics Biotech. It trades about 0.06 of its potential returns per unit of risk. Oncolytics Biotech is currently generating about -0.3 per unit of risk. If you would invest 1,271 in Day One Biopharmaceuticals on November 2, 2024 and sell it today you would earn a total of 30.00 from holding Day One Biopharmaceuticals or generate 2.36% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Day One Biopharmaceuticals vs. Oncolytics Biotech
Performance |
| Timeline |
| Day One Biopharmaceu |
| Oncolytics Biotech |
Day One and Oncolytics Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Day One and Oncolytics Biotech
The main advantage of trading using opposite Day One and Oncolytics Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Oncolytics Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncolytics Biotech will offset losses from the drop in Oncolytics Biotech's long position.| Day One vs. Surrozen | Day One vs. Armata Pharmaceuticals | Day One vs. Pasithea Therapeutics Corp | Day One vs. Aditxt Inc |
| Oncolytics Biotech vs. Scpharmaceuticals | Oncolytics Biotech vs. Milestone Pharmaceuticals | Oncolytics Biotech vs. Seres Therapeutics | Oncolytics Biotech vs. DiaMedica Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |